Ventas, Inc. (VTR)

FairStock Score: 35/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Ventas is a large healthcare REIT with roughly 1,450 properties and a real tailwind from aging demographics. The business has scale and essential assets, but I would call its moat narrow, not wide: FairStock's ROE of 2.01% and ROCE of 2.17% are thin, and the P/E of 158.95 at the $87.42 close on 2026-10-26 is distorted by depreciation anyway. For a REIT, FFO/AFFO are the right measures, and they are not in the data, so I lean on P/B of 3.06, the 2.40% dividend yield, leverage and revenue trend. The trend is improving. In fiscal FY2025, revenue was $5.8B and net income $261.5M, versus FY2024 revenue of $4.9B and net income $88.4M; the company had lost $30.3M in FY2023, which explains FairStock's computed TURNAROUND category. In fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $1.7B and net income $72.2M, after fiscal Q1 2026 revenue of $1.7B and net income $59.0M. Financial health is mixed. Debt/equity of 0.85 and a FairStock Altman Z-score of 1.84 are not comforting, though the Piotroski F-score of 7/9 and $1.1B trailing FCF are positives. At 3.06 times book with a 2.40% yield, the price already reflects a lot of improvement; FairStock's 37/100 score and very high PEG of 46.69 argue for caution. I want evidence that FFO/AFFO and cash flow per share are rising before calling the valuation attractive.

In plain English: Ventas owns senior housing and healthcare buildings and earns money from rent and services to an aging population. Sales have grown and the company has swung back to a profit, but profit is thin and debt is meaningful. At the recent price, the shares look expensive compared with reported earnings and the value of the company's assets, and more property cash-flow detail is needed to judge it fully.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-26 close · note generated 2026-10-28 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer